Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Study of Pemetrexed for Second-Line Pancreas Cancer
| Conditions: | Pancreas Cancer |
| Start Date: | October 1, 2007 |
| Phase: | Phase II |
| Status: | Terminated |
| NCT ID: | NCT00864513 |
| Study Type: | Interventional |
| Intervention: | Drug: pemetrexed |
| Study Design: | Allocation: Non-Randomized|Control: Active Control|Endpoint Classification: Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Georgetown University|Eli Lilly and Company |
| Ages: | Adult|Senior |
| Enrollment: | 17 |
| Funded By: | Other|Industry |
| First Received: | March 17, 2009 |
| End Date: | July 1, 2009 |
| Last Updated: | August 18, 2009 |
| Last Verified: | August 1, 2009 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
